Philip K. Yachmetz, EVP, Chief Business Officer at SAVIENT PHARMACEUTICALS INC (SVNT), sold 4,816 shares at $20.01 ($96K) on 2008-02-15, disclosed to the SEC on 2008-02-20.
Scheduled sale ($96k) by EVP, Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.01 | 2,361 | $47K | 49.0% |
| 2 | $20.01 | 2,455 | $49K | 51.0% |
| Total | $20.01 avg | 4,816 | $96K | 100% |
| Filing → |
| SVNT | SELL | 2013-01-16 | $1K | — | Filing → |
| SVNT | SELL | 2012-02-23 | $7K | — | Filing → |
| SVNT | BUY | 2011-09-16 | $29K | — | Filing → |